Clinical Trial to Evaluate Safety of Allogeneic Bone Marrow Derived Mesenchymal Stem Cell in Chronic Kidney Disease
Condition(s):Chronic Kidney Disease Stage 3B; Chronic Kidney Disease stage4Last Updated:March 22, 2024Completed
Hide Studies Not Open or Pending
Condition(s):Chronic Kidney Disease Stage 3B; Chronic Kidney Disease stage4Last Updated:March 22, 2024Completed
Condition(s):End-Stage Renal DiseaseLast Updated:May 26, 2010Completed
Condition(s):Chronic Kidney DiseasesLast Updated:September 8, 2023Active, not recruiting
Condition(s):Stage 2-5 Chronic Kidney Disease; PredialysisLast Updated:November 7, 2014Completed
Condition(s):Chronic Kidney DiseasesLast Updated:August 23, 2022Recruiting
Condition(s):Chronic Kidney DiseaseLast Updated:May 21, 2021Completed
Condition(s):Chronic Kidney Disease; HypomagnesemiaLast Updated:April 28, 2015Completed
Condition(s):Chronic Kidney DiseaseLast Updated:February 28, 2018Withdrawn
Condition(s):CKD Stage 4; CKD Stage 5Last Updated:October 16, 2023Enrolling by invitation
Condition(s):Chronic Kidney Disease; Cardiovascular DiseaseLast Updated:May 21, 2008Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.